Study: New HIV combination treatment easier to tolerate

01/19/2006 | HealthDay News

A study comparing a new three-drug treatment for HIV/AIDS patients with an older drug regimen in use since the mid-1990s shows the newer combination caused fewer side effects and was easier for patients to tolerate. The study, reported in the New England Journal of Medicine, tenofovir DF, emtricitabine and efavirenz, which currently are available in two pills and may be combined in one pill soon, the researchers said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT